Receiver-operating-characteristic analysis of an automated program for analyzing striatal uptake of 123I-ioflupane SPECT images: Calibration using visual reads

Journal of Nuclear Medicine Technology

Volumn 41, Issue 1, 2013, Pages 26-31

  Kuo, Phillip Hsin ^a   Avery, Ryan ^a   Krupinski, Elizabeth ^b   Lei, Hong ^a   Bauer, Adam ^a   Sherman, Scott ^a   McMillan, Natalie ^a   Seibyl, John ^b,c   Zubal, George ^b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain SPECT; Datscan; Ioflupane; Molecular neuroimaging; Software analysis

Indexed keywords

IOFLUPANE I 123;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PUTAMEN; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; AUTOMATION; BIOLOGICAL TRANSPORT; CALIBRATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOSTRIATUM; NORTROPANES; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84874965806     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.112.114827     Document Type: Article

References (34)

1. Innis RB, Seibyl JP, Scanley BE, et al. Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci USA. 1993;90:11965-11969.
2. 123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol. 2004;61:1224-1229.
3. Laruelle M, D'Souza CD, Baldwin RM, et al. Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology. 1997;17:162-174.
4. Marek K, Jennings D, Seibyl J. Single-photon emission tomography and dopamine transporter imaging in Parkinson's disease. Adv Neurol. 2003;91:183-191.
5. Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005;64:208-215.
6. Seibyl J, Jennings D, Tabamo R, Marek K. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease. Minerva Med. 2005;96:353-364.
7. 123I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov Disord. 2001;16: 1023-1032.
8. Seibyl J, Jennings D, Tabamo R, Marek K. Unique roles of SPET brain imaging in clinical and research studies: lessons from Parkinson's disease research. Q J Nucl Med Mol Imaging. 2005;49:215-221.
9. 123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. Neurology. 2001;57:2089-2094.
10. 123I-FP-CIT in de novo idiopathic Parkinson's disease patients. Eur J Nucl Med Mol Imaging. 2008;35:2220-2226.
11. 123I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging. 2008;35:424-438.
12. 123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med. 2001;28:266-272.
13. Tatsch K. Imaging of the dopaminergic system in differential diagnosis of dementia. Eur J Nucl Med Mol Imaging. 2008;35(suppl 1):S51-S57.
14. 99m)Tc-labelled radiopharmaceuticals. Eur J Nucl Med Mol Imaging. 2002;29:BP36-BP42.
15. 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging. 2008;35:1367-1376.
16. 123I]FP-CIT SPECT in early-onset parkin disease. Neurology. 2004;63:2097-2103.
17. 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. J Nucl Med. 2007;48:359-366.
18. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms. Nucl Med Commun. 2005;26:421-426.
19. 123I]FP-CIT-SPET binding in Parkinson's disease. Neurol Sci. 2006;27:397-401.
20. 123I-FP-CIT SPECT. J Nucl Med Technol. 2007;35:21-26.
21. Tatsch K, Poepperl G. Quantitative approaches to dopaminergic brain imaging. Q J Nucl Med Mol Imaging. 2012;56:27-38.
22. 123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33: 1491-1499.
23. Zubal IG, Early M, Yuan O, Jennings D, Marek K, Seibyl JP. Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson's disease patients. J Nucl Med. 2007;48:857-864.
24. MathWorks. MATLAB. Available at: http://www.mathworks.com/products/matlab/.
25. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC. Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr. 1998;22:139-152.
26. Faber TL, Cooke CD, Folks RD, et al. Left ventricular function and perfusion from gated SPECT perfusion images: an integrated method. J Nucl Med. 1999; 40:650-659.
27. Germano G, Kavanagh PB, Chen J, et al. Operator-less processing of myocardial perfusion SPECT studies. J Nucl Med. 1995;36:2127-2132.
28. Germano G, Kavanagh PB, Su HT, et al. Automatic reorientation of three-dimensional, transaxial myocardial perfusion SPECT images. J Nucl Med. 1995;36:1107-1114.
29. Liu YH, Sinusas AJ, Khaimov D, Gebuza BI, Wackers FJ. New hybrid countand geometry-based method for quantification of left ventricular volumes and ejection fraction from ECG-gated SPECT: methodology and validation. J Nucl Cardiol. 2005;12:55-65.
30. 99mTc-MAG3 scans to detect renal obstruction. J Nucl Med. 2006;47:320-329.
31. Buchert R, Berding G, Wilke F, et al. IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies. Eur J Nucl Med Mol Imaging. 2006;33:1073-1083.
32. Koch W, Hamann C, Welsch J, Popperl G, Radau PE, Tatsch K. Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies? J Nucl Med. 2005;46:1804-1811.
33. 123I-FP-CIT. Nuklearmedizin. 2007;46:107-111.
34. 123I-IBZM uptake in the striatum applied to parkinsonism. J Nucl Med. 2000;41:220-227.